Ray Dalio’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-413,699
Closed -$21.4M 1160
2025
Q4
$21.4M Sell
413,699
-60,790
-13% -$3.71M 0.08% 191
2025
Q3
$35.3M Sell
474,489
-510,759
-52% -$37.5M 0.14% 121
2025
Q2
$75.3M Buy
985,248
+484,768
+97% +$34.9M 0.3% 67
2025
Q1
$34.9M Buy
500,480
+277,783
+125% +$19.2M 0.16% 118
2024
Q4
$13.6M Buy
+222,697
New +$14.6M 0.06% 214
2023
Q1
Sell
-12,071
Closed -$314K 842
2022
Q4
$314K Buy
+12,071
New +$330K ﹤0.01% 770
2022
Q3
Sell
-15,077
Closed -$221K 977
2022
Q2
$221K Buy
15,077
+3,286
+28% +$68.5K ﹤0.01% 968
2022
Q1
$316K Buy
+11,791
New +$316K ﹤0.01% 931

Other funds holding NTNX

Ray Dalio's NTNX Position: Q1 2026 in Review

Ray Dalio sold out of Nutanix (NTNX) in Q1 2026, closing a stake of 413,699 shares — an estimated $21.4M sold.

Ray Dalio first reported a position in NTNX in Q1 2022 and held it in 8 quarters. The position peaked at $75.3M in Q2 2025. 535 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • Ray Dalio reported no remaining Nutanix position as of Q1 2026 after selling out during the quarter.
  • Ray Dalio sold 413,699 Nutanix shares in Q1 2026, an estimated $21.4M.
  • Ray Dalio first reported a position in Nutanix in Q1 2022 and held it in 8 quarters.
  • Ray Dalio's Nutanix position peaked at $75.3M in Q2 2025.
  • 535 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.